The Latest in Neurology

Internal Medicine News

Fremanezumab may reduce chronic migraine frequency

November 29, 2017

Internal Medicine News

Intepirdine flops in phase 3 study of mild to moderate Alzheimer’s patients

November 28, 2017

Internal Medicine News

Development of a sigma 1 receptor agonist for Alzheimer’s proceeds based on 2-year phase 2 data

November 21, 2017

Internal Medicine News

Long-term cholinesterase inhibition may slow cognitive decline – and more

November 15, 2017

Internal Medicine News

Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis study

November 14, 2017

Internal Medicine News

Direct oral anticoagulants okay during AF device placement

November 14, 2017

Internal Medicine News

Salivary biomarker identified for Huntington’s disease

November 13, 2017

Internal Medicine News

Delay predicting outcome in comatose cardiac arrest

November 13, 2017

Internal Medicine News

Unblinded data show extent of verubecestat’s failure in mild-moderate Alzheimer’s

November 12, 2017

Internal Medicine News

Late-Breaking Science preview: Tuesday, Nov. 14

November 9, 2017

Internal Medicine News

Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosis

November 9, 2017

Internal Medicine News

New BACE1 study launches in the shadow of verubecestat’s demise

November 4, 2017

Internal Medicine News

Aducanumab continues to rack up positive numbers in phase 1b open-label extension

November 3, 2017

Internal Medicine News

Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum

November 2, 2017

Internal Medicine News

VIDEO: Smartphones could ‘democratize’ EEG

November 1, 2017

Neurology